PL3621963T3 - Związki do leczenia epilepsji, zaburzeń neurodegeneracyjnych i innych zaburzeń oun - Google Patents
Związki do leczenia epilepsji, zaburzeń neurodegeneracyjnych i innych zaburzeń ounInfo
- Publication number
- PL3621963T3 PL3621963T3 PL18728316.3T PL18728316T PL3621963T3 PL 3621963 T3 PL3621963 T3 PL 3621963T3 PL 18728316 T PL18728316 T PL 18728316T PL 3621963 T3 PL3621963 T3 PL 3621963T3
- Authority
- PL
- Poland
- Prior art keywords
- disorders
- epilepsy
- compounds
- treatment
- cns
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 206010015037 epilepsy Diseases 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17170674 | 2017-05-11 | ||
| PCT/EP2018/062199 WO2018206760A1 (en) | 2017-05-11 | 2018-05-11 | Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3621963T3 true PL3621963T3 (pl) | 2024-05-20 |
Family
ID=58701546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18728316.3T PL3621963T3 (pl) | 2017-05-11 | 2018-05-11 | Związki do leczenia epilepsji, zaburzeń neurodegeneracyjnych i innych zaburzeń oun |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11548881B2 (pl) |
| EP (1) | EP3621963B1 (pl) |
| JP (1) | JP7158466B2 (pl) |
| CN (1) | CN110650955B (pl) |
| AU (1) | AU2018265478B2 (pl) |
| CA (1) | CA3060481C (pl) |
| DK (1) | DK3621963T3 (pl) |
| EA (1) | EA201992397A1 (pl) |
| ES (1) | ES2977619T3 (pl) |
| PL (1) | PL3621963T3 (pl) |
| WO (1) | WO2018206760A1 (pl) |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005723A1 (fr) | 1988-11-24 | 1990-05-31 | Yoshitomi Pharmaceutical Industries, Ltd. | Composes de trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane et leur utilisation en medecine |
| IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| ES2166786T3 (es) | 1993-10-01 | 2002-05-01 | Astrazeneca Ab | Procedimiento i. |
| US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
| AU2012199A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
| AU2010299A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs os aspartyl protease inhibitors |
| EP1042280A2 (en) | 1997-12-24 | 2000-10-11 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US20040248957A1 (en) | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Heterocyclic compounds and uses thereof |
| US20050182125A1 (en) | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
| WO2006110918A1 (en) * | 2005-04-13 | 2006-10-19 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
| EP2002834A1 (de) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors |
| CA2698527A1 (en) | 2007-09-20 | 2009-03-26 | Solvay Pharmaceuticals B.V. | 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| EP2149552A1 (de) * | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors |
| GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| RU2012129882A (ru) | 2009-12-16 | 2014-01-27 | Нейропор Терапиз, Инк. | Соединение |
| AU2014302458A1 (en) | 2013-06-26 | 2015-12-24 | Proteostasis Therapeutics, Inc. | Methods of modulating CFTR activity |
| US12178805B2 (en) | 2017-05-11 | 2024-12-31 | Remynd N.V. | Inhibitors of PDE6Delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disorders |
-
2018
- 2018-05-11 PL PL18728316.3T patent/PL3621963T3/pl unknown
- 2018-05-11 EA EA201992397A patent/EA201992397A1/ru unknown
- 2018-05-11 EP EP18728316.3A patent/EP3621963B1/en active Active
- 2018-05-11 US US16/612,096 patent/US11548881B2/en active Active
- 2018-05-11 AU AU2018265478A patent/AU2018265478B2/en active Active
- 2018-05-11 DK DK18728316.3T patent/DK3621963T3/da active
- 2018-05-11 JP JP2020512915A patent/JP7158466B2/ja not_active Expired - Fee Related
- 2018-05-11 CA CA3060481A patent/CA3060481C/en active Active
- 2018-05-11 CN CN201880030677.6A patent/CN110650955B/zh active Active
- 2018-05-11 WO PCT/EP2018/062199 patent/WO2018206760A1/en not_active Ceased
- 2018-05-11 ES ES18728316T patent/ES2977619T3/es active Active
-
2022
- 2022-11-22 US US18/058,109 patent/US11939324B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11548881B2 (en) | 2023-01-10 |
| JP2020519692A (ja) | 2020-07-02 |
| EP3621963B1 (en) | 2024-01-24 |
| JP7158466B2 (ja) | 2022-10-21 |
| DK3621963T3 (da) | 2024-04-15 |
| EP3621963A1 (en) | 2020-03-18 |
| US11939324B2 (en) | 2024-03-26 |
| US20230099111A1 (en) | 2023-03-30 |
| ES2977619T3 (es) | 2024-08-27 |
| AU2018265478A1 (en) | 2019-11-07 |
| CA3060481C (en) | 2024-04-30 |
| CA3060481A1 (en) | 2018-11-15 |
| US20200095238A1 (en) | 2020-03-26 |
| EA201992397A1 (ru) | 2020-03-16 |
| CN110650955B (zh) | 2023-07-25 |
| CN110650955A (zh) | 2020-01-03 |
| WO2018206760A1 (en) | 2018-11-15 |
| AU2018265478B2 (en) | 2022-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
| IL275506A (en) | Preparations and methods for the treatment of central nervous system disorders | |
| IL275562A (en) | Preparations and methods for the treatment of central nervous system disorders | |
| IL273705A (en) | Benzothiazole compounds and methods of using them for the treatment of neurodegenerative diseases | |
| IL267818A (en) | Methods for treating neurological disorders | |
| IL253914A0 (en) | 1-Heterocyclyl isochromanyl compounds and analogs for the treatment of cns disorders | |
| IL257908A (en) | Methods for the treatment of epilepsy | |
| ZA202002993B (en) | Compounds for the treatment of neuromuscular disorders | |
| PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
| GB201803010D0 (en) | Neurodegenerative disorders | |
| IL259674B (en) | Benzofuran derivatives for the treatment of diseases related to the central nervous system and other diseases | |
| PT3458067T (pt) | Tratamento de distúrbios neurológicos | |
| IL280424A (en) | Methods for treating neurodegenerative disorders | |
| IL276966A (en) | Epilepsy treatment factor | |
| ZA201700037B (en) | Compounds for the treatment of seizures and other central nervous system disorders and conditions | |
| GB201713760D0 (en) | Treatment of epilepsy | |
| SG11201706952VA (en) | Compositions and methods for the treatment of epilepsy and neurological disorders | |
| PT3724173T (pt) | Compostos para o tratamento de distúrbios neuromusculares | |
| DK3621963T3 (da) | Forbindelser til behandling af epilepsi, neurodegenerative lidelser og andre CNS-lidelser | |
| HK40019969A (en) | Compounds for use in methods for treating alzheimer's disease | |
| GB201713762D0 (en) | Treatment of epilepsy |